Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,445.00
Bid: 1,435.00
Ask: 1,437.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.139%)
Open: 1,485.00
High: 1,485.00
Low: 1,410.00
Prev. Close: 1,445.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE 100 Charges Ahead Even As Rolls-Royce Drags

Tue, 26th Jan 2021 12:12

(Alliance News) - London stocks on Tuesday bounced back from a soft start to the week as markets look ahead of a busy week for US corporate earnings and hang on to Washington stimulus hopes.

Rolls-Royce pared early losses in the FTSE 100 while Indivior rallied to the top of the mid-cap FTSE 250.

The FTSE 100 index was up 45.31 points, or 0.7%, at 6,684.16 on Tuesday. The FTSE 250 index was up 138.21 points, or 0.4%, at 20,488.62. The AIM All-Share index was down 0.3% at 1,195.57.

The Cboe UK 100 index was up 0.8% at 664.52. The Cboe 250 was up 0.7% at 17,799.97, and the Cboe Small Companies down 0.4% at 12,176.09.

"Investors seem willing to look past [Friday's] poor PMI data, either reasoning that things will get better from here as vaccination programmes ramp up, or more likely they have nowhere else to go given the lack of income available outside equities," said Chris Beauchamp, chief market analyst at IG.

"The rally since November has slowed noticeably, but it has yet to move to the downside, and instead most indices are content to tread water, with a decent earnings season in the US and expectations of fiscal stimulus providing a reason to hang around the party until the situation improves."

US corporate earnings continue on Tuesday, with Microsoft and American Express among some of the companies reporting. Later in the week come results from the likes of Apple, Boeing, Facebook, Tesla and Visa.

Ahead of the reports, Wall Street was pointed to a mixed open. The Dow Jones is called up 0.1%, the S&P 500 down 0.1% and the Nasdaq Composite down 0.2%.

In mainland Europe, the CAC 40 in Paris was up 1.0% while the DAX 30 in Frankfurt surged 1.4% on Tuesday. The euro was higher, at USD1.2164 versus USD1.2125 late Monday.

Sterling firmed to USD1.3670 at midday from USD1.3655 at the London equities close on Monday.

The unemployment rate for the three months to November came in at 5.0%, up from 4.9% in the three months to October but beating consensus, according to FXStreet, of a steeper rise to 5.1%.

Early estimates for December indicate that the number of payrolled employees fell by 2.7% compared with a year ago, marking a fall of 793,000 employees, the ONS said. Since February - being the month before the coronavirus pandemic gripped the UK - 828,000 fewer people were in payrolled employment.

Safe haven assets, the Japanese yen and gold, were mildly higher on Tuesday. Against the yen, the dollar was quoted at JPY103.78 versus JPY103.81. Gold was quoted at USD1,851.69 an ounce on Tuesday, a touch higher than USD1,848.02 at the London equities close on Monday.

Brent oil was trading at USD56.31 a barrel, rising from USD55.50 late Monday. Oil majors tracked the price of Brent higher, with BP shares up 1.5% at midday, while Royal Dutch Shell 'A' and 'B' shares both rose 1.4%.

Rolls-Royce remained rooted at the bottom of the FTSE 100 but had managed to pare losses by midday. The stock was down 4.5% at 93.62 pence at midday, having traded below the 90p mark earlier in the session.

The jet engine maker said new coronavirus strains and the tighter travel restrictions introduced in their wake is creating short-term uncertainty.

"Continued progress on vaccination programmes is encouraging for the medium-term recovery of air traffic and economic activity. In the near-term, however, more contagious variants of the virus are creating additional uncertainty," Rolls-Royce explained.

Its current forecasts indicate free cash outflow in the region of GBP2 billion in 2021. This is based on widebody engine flying hours for this year at around 55% of 2019 levels, compared to a base case of 70% presented in October.

Russ Mould, investment director at AJ Bell, commented: "The market will be keeping a close eye on the state of the aviation industry and whether the second half of 2021 is realistic for a notable increase in the number of planes flying. That matters for Rolls-Royce as its real money is made from repair and maintenance work rather than the sale of engines, and that requires planes to be in the sky."

JD Sports Fashion fell 1.5% after the sportswear retailer confirmed it is looking into the possibility of an equity raise to fund its expansion.

The FTSE 100-listed sportswear retailer said it is exploring additional funding options with a view to "increasing its flexibility to invest in future strategic opportunities", which could potentially involve a non pre-emptive equity placing. The company didn't put a figure on the potential raise.

On Monday, Sky News reported JD was in talks over an around GBP400 million share sale to fund its expansion.

Among blue-chip stocks in the green at midday was Compass, up 3.3% after Exane raised the contract caterer to Neutral from Underperform.

At the top of the FTSE 250 was Indivior, rallying 11% after saying after the market close on Monday that former parent company Reckitt Benckiser has withdrawn a USD1.4 billion claim against the FTSE 250-listed drugmaker.

In November, Indivior announced that FTSE 100-listed Reckitt Benckiser had submitted a claim against the company. The claim related to an indemnity contained in the demerger agreement entered into between the two companies in November 2014.

Indivior was spun off from the consumer health and hygiene firm and listed on the London Stock Exchange in December of that year.

On Monday, Indivior said RB has agreed to withdraw the USD1.4 billion claim and to release Indivior from any claim for indemnity under the demerger agreement relating to the US Department of Justice and Federal Trade Commission settlements which RB entered into in July 2019, as well as other claims for indemnity. Indivior has agreed to pay RB a total of USD50 million over the next five years.

Reckitt shares were down 1.7% on Tuesday.

Mid-cap UDG Healthcare rose 5.1%. The healthcare services provider said it expects to post a significant rise in earnings for its current financial year as its divisions delivered a first quarter performance ahead of the prior year.

It anticipates that for its financial year ending September 30, constant currency adjusted operating profit will be between 11% to 13% ahead of the USD165.3 million reported in financial 2020. Constant currency adjusted diluted earnings per share is also expected to be between 9% to 11% ahead of the USD47.7 cents recorded the year prior.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Aug 2023 07:23

Indivior settles part of US suboxone litigation

(Sharecast News) - Addiction treatment specialist Indivior announced on Monday that its US subsidiary has entered into an agreement to settle the claims initiated by the end payor class in the ongoing multi-district suboxone antitrust litigation.

Read more
1 Aug 2023 17:39

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Jul 2023 09:46

LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
27 Jul 2023 11:48

Indivior raises 2023 guidance after strong half-year progress

(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year.

Read more
27 Jul 2023 10:04

Indivior lifts guidance after strong first half

(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.

Read more
12 Jun 2023 07:53

LONDON BRIEFING: Shares on the rise; Frasers buys into AO World

(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves.

Read more
5 Jun 2023 07:46

Indivior reaches settlement in litigation with US states

(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.

Read more
2 Jun 2023 18:18

Indivior settles antitrust claims in US regarding Suboxone drug

(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone.

Read more
25 May 2023 09:23

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
23 May 2023 09:56

Indivior emergency opioid overdose treatment approved by US FDA

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose.

Read more
23 May 2023 07:48

Indivior's opioid addiction sprat approved by FDA

(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.

Read more
10 May 2023 17:02

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
27 Apr 2023 15:49

UK shareholder meetings calendar - next 7 days

Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
ME Group International PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt Meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 4 May 
AIB Group PLCAGM
Aviva PLCAGM
Aviva PLCGM re capital reduction
BAE Systems PLCAGM
Bivictrix Therapeutics PLCAGM
Domino's Pizza Group PLCAGM
Glanbia PLCAGM
Grafton Group PLCAGM
Hammerson PLCAGM
Howden Joinery Group PLCAGM
Hurricane Energy PLCCourt Meeting & GM re takeover by Prax Exploration & Production PLC  
Indivior PLCAGM
IMI PLCAGM
Irish Residential Properties REIT PLCAGM
ITV PLCAGM
Jardine Matheson Holdings LtdAGM
Johnson Service Group PLCAGM
LungLife AI IncAGM
Mincon Group PLCAGM
Mondi PLCAGM
Moneysupermarket.com Group PLCAGM
Morgan Sindall Group PLCAGM
Spirent Communications PLCAGM
Personal Group Holdings PLCAGM
Phoenix Group Holdings PLCAGM
Rathbones Group PLCAGM
SIG PLCAGM
Ten Entertainment Group PLCAGM
Travis Perkins PLCAGM
Witan Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 14:41

Indivior lifts revenue guidance, cuts profit outlook after Opiant deal

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its full-year revenue guidance on Thursday but trimmed its outlook for operating profit due to costs related to the acquisition of Opiant Pharmaceuticals, as it posted a jump in first-quarter profit and revenue.

Read more
27 Apr 2023 13:46

Indivior raises 2023 revenue forecast following Opiant acquisition

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.